Depletion of thymosin β4 promotes the proliferation, migration, and activation of human hepatic stellate cells

Cellular Physiology and Biochemistry

Volumn 34, Issue 2, 2014, Pages 356-367

  Xiao, Yongtao ^b,c   Qu, Chunying ^a   Ge, Wensong ^a   Wang, Baocan ^a   Wu, Jianxin ^a   Xu, Leiming ^a   Chen, Yingwei ^a,c  

^a SHANGHAI JIAO TONG UNIVERSITY   (China)

^b Shanghai Institute for Pediatric Research   (China)

^c Shanghai Key Laboratory of Pediatric Gastroenterology and Nutrition   (China)

Author keywords

Hepatic stellate cell; Liver fibrosis; Migration; Proliferation; Thymosin 4

Indexed keywords

8 [4 (1 AMINOCYCLOBUTYL)PHENYL] 9 PHENYL 1,2,4 TRIAZOLO[3,4 F][1,6]NAPHTHYRIDIN 3(2H) ONE; ALPHA SMOOTH MUSCLE ACTIN; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; SMALL INTERFERING RNA; THYMOSIN BETA4; VIMENTIN; ACTA2 PROTEIN, HUMAN; ACTIN; THYMOSIN; THYMOSIN BETA(4);

ANIMAL TISSUE; ARTICLE; CELL ACTIVATION; CELL COUNTING; CELL MIGRATION; CELL PROLIFERATION; CELL VIABILITY ASSAY; CONTROLLED STUDY; DISEASE COURSE; HUMAN; HUMAN CELL; INTRACELLULAR SIGNALING; LIVER; LIVER FIBROSIS; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN DEPLETION; PROTEIN EXPRESSION; RAT; STELLATE CELL; WOUND HEALING; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; SIGNAL TRANSDUCTION; WESTERN BLOTTING; ANIMAL; CELL LINE; CELL MOTION; CYTOLOGY; GENETICS; LIVER CIRRHOSIS; METABOLISM; PHYSIOLOGY; SPRAGUE DAWLEY RAT;

ACTINS; ANIMALS; CELL LINE; CELL MOVEMENT; CELL PROLIFERATION; DISEASE PROGRESSION; HEPATIC STELLATE CELLS; HUMANS; LIVER CIRRHOSIS; MALE; PHOSPHATIDYLINOSITOL 3-KINASES; PROTO-ONCOGENE PROTEINS C-AKT; RATS; RATS, SPRAGUE-DAWLEY; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION; THYMOSIN; VIMENTIN;

EID: 84904530393     PISSN: 10158987     EISSN: 14219778     Source Type: Journal    
DOI: 10.1159/000363005     Document Type: Article

References (42)

1. Moreira RK: Hepatic stellate cells and liver fibrosis. Arch Pathol Lab Med 2007;131:1728-1734.
2. Dooley S, Hamzavi J, Breitkopf K, Wiercinska E, Said HM, Lorenzen J, Ten Dijke P, Gressner AM: Smad7 prevents activation of hepatic stellate cells and liver fibrosis in rats. Gastroenterology 2003;125:178-191.
3. Bataller R, Brenner DA: Hepatic stellate cells as a target for the treatment of liver fibrosis. Semin Liver Dis 2001;21:437-451.
4. Gabele E, Brenner DA, Rippe RA: Liver fibrosis: Signals leading to the amplification of the fibrogenic hepatic stellate cell. Front Biosci 2003;8:d69-77.
5. Marra F: Hepatic stellate cells and the regulation of liver inflammation. J Hepatol 1999;31:1120-1130.
6. Xu L, Hui AY, Albanis E, Arthur MJ, O'Byrne SM, Blaner WS, Mukherjee P, Friedman SL, Eng FJ: Human hepatic stellate cell lines, lx-1 and lx-2: New tools for analysis of hepatic fibrosis. Gut 2005;54:142-151.
7. Ho JH, Tseng KC, Ma WH, Chen KH, Lee OK, Su Y: Thymosin beta-4 upregulates anti-oxidative enzymes and protects human cornea epithelial cells against oxidative damage. Br J Ophthalmol 2008;92:992-997.
8. Peng Y, Yang H, Wang N, Ouyang Y, Yi Y, Liao L, Shen H, Hu G, Wang Z, Tao L: Fluorofenidone attenuates hepatic fibrosis by suppressing the proliferation and activation of hepatic stellate cells. Am J Physiol Gastrointest Liver Physiol 2014;306:G253-263.
9. Fang L, Zhan S, Huang C, Cheng X, Lv X, Si H, Li J: Trpm7 channel regulates pdgf-bb-induced proliferation of hepatic stellate cells via pi3k and erk pathways. Toxicol Appl Pharmacol 2013;272:713-725.
10. Barnaeva E, Nadezhda A, Hannappel E, Sjogren MH, Rojkind M: Thymosin beta4 upregulates the expression of hepatocyte growth factor and downregulates the expression of pdgf-beta receptor in human hepatic stellate cells. Ann N Y Acad Sci 2007;1112:154-160.
11. Greenwel P, Dominguez-Rosales JA, Mavi G, Rivas-Estilla AM, Rojkind M: Hydrogen peroxide: A link between acetaldehyde-elicited alpha1(i) collagen gene up-regulation and oxidative stress in mouse hepatic stellate cells. Hepatology 2000;31:109-116.
12. Malinda KM, Goldstein AL, Kleinman HK: Thymosin beta 4 stimulates directional migration of human umbilical vein endothelial cells. FASEB J 1997;11:474-481.
13. Bock-Marquette I, Saxena A, White MD, Dimaio JM, Srivastava D: Thymosin beta4 activates integrin-linked kinase and promotes cardiac cell migration, survival and cardiac repair. Nature 2004;432:466-472.
14. Zuo Y PS, Yang HC, Ma LJ, Fogo AB.: The balance of thymosin 4 and its metabolite ac-sdkp modulates activity of profibrotic factors. Modern Pathol 2010;23:Suppl 1.
15. Zuo Y, Chun B, Potthoff SA, Kazi N, Brolin TJ, Orhan D, Yang HC, Ma LJ, Kon V, Myohanen T, Rhaleb NE, Carretero OA, Fogo AB: Thymosin beta4 and its degradation product, ac-sdkp, are novel reparative factors in renal fibrosis. Kidney Int 2013;84:1166-1175.
16. Reyes-Gordillo K, Shah R, Popratiloff A, Fu S, Hindle A, Brody F, Rojkind M: Thymosin-beta4 (tbeta4) blunts pdgf-dependent phosphorylation and binding of akt to actin in hepatic stellate cells. Am J Pathol 2011;178:2100-2108.
17. Cho JJ, Hocher B, Herbst H, Jia JD, Ruehl M, Hahn EG, Riecken EO, Schuppan D: An oral endothelin-a receptor antagonist blocks collagen synthesis and deposition in advanced rat liver fibrosis. Gastroenterology 2000;118:1169-1178.
18. Boigk G, Stroedter L, Herbst H, Waldschmidt J, Riecken EO, Schuppan D: Silymarin retards collagen accumulation in early and advanced biliary fibrosis secondary to complete bile duct obliteration in rats. Hepatology 1997;26:643-649.
19. Bataille F, Rohrmeier C, Bates R, Weber A, Rieder F, Brenmoehl J, Strauch U, Farkas S, Furst A, Hofstadter F, Scholmerich J, Herfarth H, Rogler G: Evidence for a role of epithelial mesenchymal transition during pathogenesis of fistulae in crohn's disease. Inflamm Bowel Dis 2008;14:1514-1527.
20. Garg V, Kathiriya IS, Barnes R, Schluterman MK, King IN, Butler CA, Rothrock CR, Eapen RS, Hirayama-Yamada K, Joo K, Matsuoka R, Cohen JC, Srivastava D: Gata4 mutations cause human congenital heart defects and reveal an interaction with tbx5. Nature 2003;424:443-447.
21. Nemolato S, Van Eyken P, Cabras T, Cau F, Fanari MU, Locci A, Fanni D, Gerosa C, Messana I, Castagnola M, Faa G: Expression pattern of thymosin beta 4 in the adult human liver. Eur J Histochem 2011;55:e25.
22. Shuda M, Kwun HJ, Feng H, Chang Y, Moore PS: Human merkel cell polyomavirus small t antigen is an oncoprotein targeting the 4e-bp1 translation regulator. J Clin Invest 2011;121:3623-3634.
23. Safer D, Elzinga M, Nachmias VT: Thymosin beta 4 and fx, an actin-sequestering peptide, are indistinguishable. J Biol Chem 1991;266:4029-4032.
24. Sanders MC, Goldstein AL, Wang YL: Thymosin beta 4 (fx peptide) is a potent regulator of actin polymerization in living cells. Proc Natl Acad Sci U S A 1992;89:4678-4682.
25. Conte E, Genovese T, Gili E, Esposito E, Iemmolo M, Fruciano M, Fagone E, Pistorio MP, Crimi N, Cuzzocrea S, Vancheri C: Protective effects of thymosin beta4 in a mouse model of lung fibrosis. Ann N Y Acad Sci 2012;1269:69-73.
26. Rubin BK, Kater AP, Goldstein AL: Thymosin beta4 sequesters actin in cystic fibrosis sputum and decreases sputum cohesivity in vitro. Chest 2006;130:1433-1440.
27. Koutrafouri V, Leondiadis L, Avgoustakis K, Livaniou E, Czarnecki J, Ithakissios DS, Evangelatos GP: Effect of thymosin peptides on the chick chorioallantoic membrane angiogenesis model. Biochim Biophys Acta 2001;1568:60-66.
28. Malinda KM, Sidhu GS, Mani H, Banaudha K, Maheshwari RK, Goldstein AL, Kleinman HK: Thymosin beta4 accelerates wound healing. J Invest Dermatol 1999;113:364-368.
29. Badamchian M, Fagarasan MO, Danner RL, Suffredini AF, Damavandy H, Goldstein AL: Thymosin beta(4) reduces lethality and down-regulates inflammatory mediators in endotoxin-induced septic shock. Int Immunopharmacol 2003;3:1225-1233.
30. Naylor PH, McClure JE, Spangelo BL, Low TL, Goldstein AL: Immunochemical studies on thymosin: Radioimmunoassay of thymosin beta 4. Immunopharmacol 1984;7:9-16.
31. Inzitari R, Cabras T, Pisano E, Fanali C, Manconi B, Scarano E, Fiorita A, Paludetti G, Manni A, Nemolato S, Faa G, Castagnola M, Messana I: Hplc-esi-ms analysis of oral human fluids reveals that gingival crevicular fluid is the main source of oral thymosins beta(4) and beta(10). J Sep Sci 2009;32:57-63.
32. Bodendorf S, Born G, Hannappel E: Determination of thymosin beta4 and protein in human wound fluid after abdominal surgery. Ann N Y Acad Sci 2007;1112:418-424.
33. Ikeda H, Nagoshi S, Ohno A, Yanase M, Maekawa H, Fujiwara K: Activated rat stellate cells express c-met and respond to hepatocyte growth factor to enhance transforming growth factor beta1 expression and DNA synthesis. Biochem Biophys Res Commun 1998;250:769-775.
34. Kim WH, Matsumoto K, Bessho K, Nakamura T: Growth inhibition and apoptosis in liver myofibroblasts promoted by hepatocyte growth factor leads to resolution from liver cirrhosis. Am J Pathol 2005;166:1017-1028.
35. Sanchez-Valle V, Chavez-Tapia NC, Uribe M, Mendez-Sanchez N: Role of oxidative stress and molecular changes in liver fibrosis: A review. Curr Med Chem 2012;19:4850-4860.
36. Parola M, Robino G: Oxidative stress-related molecules and liver fibrosis. J Hepatol 2001;35:297-306.
37. Svegliati-Baroni G, Inagaki Y, Rincon-Sanchez AR, Else C, Saccomanno S, Benedetti A, Ramirez F, Rojkind M: Early response of alpha2(i) collagen to acetaldehyde in human hepatic stellate cells is tgf-beta independent. Hepatology 2005;42:343-352.
38. Kumar S, Gupta S: Thymosin beta 4 prevents oxidative stress by targeting antioxidant and anti-apoptotic genes in cardiac fibroblasts. PLoS One 2011;6:e26912.
39. Lauffenburger DA, Horwitz AF: Cell migration: A physically integrated molecular process. Cell 1996;84:359-369.
40. Pollard TD, Borisy GG: Cellular motility driven by assembly and disassembly of actin filaments. Cell 2003;112:453-465.
41. Fan Y, Gong Y, Ghosh PK, Graham LM, Fox PL: Spatial coordination of actin polymerization and ilk-akt2 activity during endothelial cell migration. Dev Cell 2009;16:661-674.
42. Friedman SL: Liver fibrosis - from bench to bedside. J Hepatol 2003;38:S38-53.